Loading chat...

PA SB936

Bill

Status

Introduced

7/22/2025

Primary Sponsor

Katie Muth

Click for details

Origin

Senate

2025-2026 Regular Session

AI Summary

  • Health insurance policies in Pennsylvania must provide coverage for postexposure prophylaxis (PEP) HIV medication, which is FDA-approved medication taken after potential HIV exposure to prevent transmission

  • Insurance providers are prohibited from moving PEP medication into a specialty tier solely for monetary gains

  • Health plans cannot require counseling from an infectious disease specialist or immunologist as a condition for receiving PEP medication unless medically necessary

  • Applies to individual and group health insurance policies governed under Pennsylvania insurance laws, excluding accident-only, dental, vision, Medicare supplement, long-term care, disability, and workers' compensation plans

  • Takes effect 60 days after enactment

Legislative Description

Requiring health insurance policies to provide coverage for postexposure prophylaxis HIV medication.

Last Action

Referred to Banking & Insurance

7/22/2025

Committee Referrals

Banking & Insurance7/22/2025

Full Bill Text

No bill text available